Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily

• Main Authors: Giuseppina Capra (Author), Lucia Giovannelli (Author), Domenica Matranga (Author), Carmelina Bellavia (Author), Maria Francesca Guarneri (Author), Teresa Fasciana (Author), Giovanna Scaduto (Author), Alberto Firenze (Author), Alessandra Vassiliadis (Author), Antonio Perino (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

While bivalent and quadrivalent HPV vaccines have been used for about 10 years, a nonavalent vaccine against HPV types 6/11/16/18/31/33/45/52 and 58 has been recently approved by FDA and EMA and is now commercially available. The objective of our study was to evaluate the potential impact of the non...